DXR · Daxor Corp
United States · RS rating 24 · As of 2026-11-03
| Price | 8.70 USD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 24 / 23 / 35 / 28 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 8 / 18 |
| Industry group (rank) | Medical-Systems/Equip (86) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +41.0% |
| Market cap (USD) | $56.9M |